AAAAAA
Results:
1-22
|
Results: 22
Authors:
Sonneveld, P
List, AF
Citation: P. Sonneveld et Af. List, Chemotherapy resistance in acute myeloid leukaemia, BEST P R C, 14(1), 2001, pp. 211-233
Authors:
Sonneveld, P
Citation: P. Sonneveld, Multidrug resistance in haematological malignancies (Reprinted from Journal of Internal Medicine, vol 247, pg 521-534, 2000), J INTERN M, 249, 2001, pp. 47-60
Authors:
van den Heuvel-Eibrink, MM
Wiemer, EAC
Kuijpers, M
Pieters, R
Sonneveld, P
Citation: Mm. Van Den Heuvel-eibrink et al., Absence of mutations in the deoxycytidine kinase (dCK) gene in patients with relapsed and/or refractory acute myeloid leukemia (AML), LEUKEMIA, 15(5), 2001, pp. 855-856
Authors:
van den Heuvel-Eibrink, MM
Wiemer, EAC
de Boevere, MJ
Slater, RM
Smit, EME
van Noesel, MM
van der Holt, B
Schoester, M
Pieters, R
Sonneveld, P
Citation: Mm. Van Den Heuvel-eibrink et al., MDR1 expression in poor-risk acute myeloid leukemia with partial or complete monosomy 7, LEUKEMIA, 15(3), 2001, pp. 398-405
Authors:
van Zon, A
Mossink, MH
Schoester, M
Scheffer, GL
Scheper, RJ
Sonneveld, P
Wiemer, EAC
Citation: A. Van Zon et al., Multiple human vault RNAs - Expression and association with the vault complex, J BIOL CHEM, 276(40), 2001, pp. 37715-37721
Authors:
de Lange, P
Segeren, CM
Koper, JW
Wiemer, E
Sonneveld, P
Brinkmann, AO
White, A
Brogan, IJ
de Jong, FH
Lamberts, SW
Citation: P. De Lange et al., Expression in hematological malignancies of a glucocorticoid receptor splice variant that augments glucocorticoid receptor-mediated effects in transfected cells, CANCER RES, 61(10), 2001, pp. 3937-3941
Authors:
van den Heuvel-Eibrink, MM
Wiemer, EAC
de Boevere, MJ
van der Holt, B
Vossebeld, PJM
Pieters, R
Sonneveld, P
Citation: Mm. Van Den Heuvel-eibrink et al., MDR1 gene-related clonal selection and P-glycoprotein function and expression in relapsed or refractory acute myeloid leukemia, BLOOD, 97(11), 2001, pp. 3605-3611
Authors:
Sonneveld, P
Citation: P. Sonneveld, Multidrug resistance in haematological malignancies, J INTERN M, 247(5), 2000, pp. 521-534
Authors:
van den Heuvel-Eibrink, MM
Sonneveld, P
Pieters, R
Citation: Mm. Van Den Heuvel-eibrink et al., The prognostic significance of membrane transport-associated multidrug resistance (MDR) proteins in leukemia, INT J CL PH, 38(3), 2000, pp. 94-110
Authors:
Broxterman, HJ
Sonneveld, P
van Putten, WJL
Lankelma, J
Eekman, CA
Ossenkoppele, GJ
Pinedo, HM
Lowenberg, B
Schuurhuis, GJ
Citation: Hj. Broxterman et al., P-glycoprotein in primary acute myeloid leukemia and treatment outcome of idarubicin/cytosine arabinoside-based induction therapy, LEUKEMIA, 14(6), 2000, pp. 1018-1024
Authors:
Doorduijn, JK
Spruit, PH
Van der Holt, B
Van't Veer, MB
Budel, LM
Lowenberg, B
Sonneveld, P
Citation: Jk. Doorduijn et al., Etoposide, mitoxantrone and prednisone, a salvage regimen with low toxicity for refractory or relapsed non-Hodgkin's lymphoma, HAEMATOLOG, 85(8), 2000, pp. 814-819
Authors:
Hintzen, RQ
Voormolen, J
Sonneveld, P
van Duinen, SG
Citation: Rq. Hintzen et al., Glioblastoma causing granulocytosis by secretion of granulocyte-colony-stimulating factor, NEUROLOGY, 54(1), 2000, pp. 259-261
Authors:
Danen, EHJ
Sonneveld, P
Sonnenberg, A
Yamada, KM
Citation: Ehj. Danen et al., Dual stimulation of Ras/Mitogen-activated protein kinase and RhoA by cell adhesion to fibronectin supports growth factor-stimulated cell cycle progression, J CELL BIOL, 151(7), 2000, pp. 1413-1422
Authors:
Willems, P
Verhagen, O
Segeren, C
Veenhuizen, P
Guikema, J
Wiemer, E
Groothuis, L
Buitenweg-de Jong, T
Kok, H
Bloem, A
Bos, N
Vellenga, E
Mensink, E
Sonneveld, P
van der Schoot, HLE
Raymakers, R
Citation: P. Willems et al., Consensus strategy to quantitate malignant cells in myeloma patients is validated in a multicenter study, BLOOD, 96(1), 2000, pp. 63-70
Authors:
Ossenkoppele, GJ
van der Holt, B
Verhoef, GEG
Daenen, SMGJ
Verdonck, LF
Sonneveld, P
Wijermans, PW
van der Lelie, J
van Putten, WLJ
Lowenberg, B
Citation: Gj. Ossenkoppele et al., A randomized study of granulocyte colony-stimulating factor applied duringand after chemotherapy in patients with poor risk myelodysplastic syndromes: a report from the HOVON Cooperative Group, LEUKEMIA, 13(8), 1999, pp. 1207-1213
Authors:
Broxterman, HJ
Sonneveld, P
Pieters, R
Lankelma, J
Eekman, CA
Loonen, AH
Schoester, M
Ossenkoppele, GJ
Lowenberg, B
Pinedo, HM
Schuurhuis, GJ
Citation: Hj. Broxterman et al., Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia, LEUKEMIA, 13(2), 1999, pp. 258-265
Authors:
Sonneveld, P
Citation: P. Sonneveld, Drug resistance in multiple myeloma, PATH BIOL, 47(2), 1999, pp. 182-187
Authors:
Vossebeld, PJM
Sonneveld, P
Citation: Pjm. Vossebeld et P. Sonneveld, Reversal of multidrug resistance in hematological malignancies, BLOOD REV, 13(2), 1999, pp. 67-78
Authors:
Lokhorst, HM
Sonneveld, P
Cornelissen, JJ
Joosten, P
Kooy, MV
Meinema, J
Nieuwenhuis, HK
van Oers, MHJ
Richel, DJ
Segeren, CN
Veth, G
Verdonck, LF
Wijermans, PW
Citation: Hm. Lokhorst et al., Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma, BONE MAR TR, 23(4), 1999, pp. 317-322
Authors:
Lokhorst, HM
Sonneveld, P
Verdonck, LF
Citation: Hm. Lokhorst et al., Intensive treatment for multiple myeloma: Where do we stand?, BR J HAEM, 106(1), 1999, pp. 18-27
Authors:
Segeren, CM
Sonneveld, P
van der Holt, B
Baars, JW
Biesma, DH
Cornellissen, JJ
Croockewit, AJ
Dekker, AW
Fibbe, WE
Lowenberg, B
Kooy, MV
van Oers, MHJ
Richel, DJ
Schouten, HC
Vellenga, E
Verhoef, GEG
Wijermans, PW
Wittebol, S
Lokhorst, HM
Citation: Cm. Segeren et al., Vincristine, doxorubicin and dexamethasone (VAD) administered as rapid intravenous infusion for first-line treatment in untreated multiple myeloma, BR J HAEM, 105(1), 1999, pp. 127-130
Authors:
Jansen, JH
de Ridder, MC
Geertsma, WMC
Erpelinck, CAJ
van Lom, K
Smit, EME
Slater, R
van der Reijden, BA
de Greef, GE
Sonneveld, P
Lowenberg, B
Citation: Jh. Jansen et al., Complete remission of t(11;17) positive acute promyelocytic leukemia induced by all-trans retinoic acid and granulocyte colony-stimulating factor, BLOOD, 94(1), 1999, pp. 39-45
Risultati:
1-22
|